Abstract
Background
There is a lack of data on the effect of high postoperative body temperature on disease-free survival (DFS) in patients who underwent radical gastrectomy.
Methods
Patients who underwent radical gastrectomy from January 2006 to December 2011 were selected. The highest body temperature within 1 week after operation was used to establish diagnostic thresholds for high and low body temperature through X-tile software.
Results
A total of 1396 patients were included in the analysis. The diagnostic threshold for high body temperature was defined as 38 °C; 370 patients were allocated to the high-temperature group (HTG), while another 1026 patients were allocated to the low-temperature group (LTG). For all patients, survival analysis showed that 5-year DFS in the HTG was significantly lower than that for the LTG (55.6% vs 63.9%, P = 0.007). Multivariate analysis revealed that high postoperative body temperature was an independent prognostic risk factor for 5-year DFS (HR = 1.288 (1.067–1.555), P = 0.008). For patients without complications, survival analysis showed that the 5-year DFS rate in the HTG was lower than that for the LTG (57.5% vs 64.4%, P = 0.051), especially in patients with stage III gastric cancer (31.3% vs 41.7%, P = 0.037). For patients with complications or infectious complications, there were no significant differences between the HTG and LTG regarding 5-year DFS (49.3% vs 58.2%, P = 0.23 and 49.4% vs 55.1%, P = 0.481, respectively).
Conclusion
For stage III gastric cancer patients without complications, high postoperative body temperature can significantly reduce the 5-year DFS. These patients may benefit from more aggressive adjuvant therapy and postoperative surveillance regimens.
Similar content being viewed by others
References
Jemal A, Bray F, Center MM et al (2011) Global cancer statistics. CA Cancer J Clin 61:69–90
Kamangar F, Dores GM, Anderson WF (2006) Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24:2137–2150
Maruyama K, Kaminishi M, Hayashi K, Isobe Y, Honda I, Katai H et al (2006) Gastric cancer treated in 1991 in Japan: data analysis of nationwide registry. Gastric Cancer 9:51–66
Isobe Y, Nashimoto A, Akazawa K, Oda I, Hayashi K, Miyashiro I et al (2011) Gastric cancer treatment in Japan: 2008 annual report of the JGCA nationwide registry. Gastric Cancer 14:301–316
Maehara Y, Hasuda S, Koga T, Tokunaga E, Kakeji Y, Sugimachi K (2000) Postoperative outcome and sites of recurrence in patients following curative resection of gastric cancer. Br J Surg 87:353–357
Shiraishi N, Inomata M, Osawa N, Yasuda K, Adachi Y, Kitano S (2000) Early and late recurrence after gastrectomy for gastric carcinoma. Univariate and multivariate analyses. Cancer 89:255–261
Adachi Y, Oshiro T, Mori M, Maehara Y, Sugimachi M (1996) Prediction of early and late recurrence after curative resection for gastric carcinoma. Cancer 77:2445–2448
Maruyama K (1987) The most important prognostic factors for gastric cancer patients. Scand J Gastroenterol 22:63–68
Sierzega M, Kolodziejczyk P, Kulig J (2010) Impact of anastomotic leakage on long-term survival after total gastrectomy for carcinoma of the stomach. Br J Surg 97:1035–1042
Tokunaga M et al (2013) Poor survival rate in patients with postoperative intra-abdominal infectious complications following curative gastrectomy for gastric cancer. Ann Surg Oncol 20(5):1575–1583
Walker KG, Bell SW, Rickard MJ, Mehanna D, Dent OF, Chapuis PH et al (2004) Anastomotic leakage is predictive of diminished survival after potentially curative resection for colorectal cancer. Ann Surg 240:255–259
Hirai T, Yamashita Y, Mukaida H, Kuwahara M, Inoue H, Toge T (1998) Poor prognosis in esophageal cancer patients with postoperative complications. Surg Today 28:576–579
Rizk NP, Bach PB, Schrag D, Bains MS, Turnbull AD, Karpeh M et al (2004) The impact of complications on outcomes after resection for esophageal and gastroesophageal junction carcinoma. J Am Coll Surg 198:42–50
Artinyan A et al (2015) Infectious postoperative complications decrease long-term survival in patients undergoing curative surgery for colorectal cancer. Ann Surg 261(3):497–505
Fanning J et al (1998) Frequency and yield of postoperative fever evaluation. Infect Dis Obstet Gynecol 6(6):252–255
Swisher ED, Kahleifeh B, Pohl JF (1997) Blood cultures in febrile patients after hysterectomy. Cost-effectiveness. J Reprod Med 42(9):547–550
De la Torre SH, Mandel L, Goff BA (2003) Evaluation of postoperative fever: usefulness and cost-effectiveness of routine workup. Am J Obstet Gynecol 188(6):1642–1647
Garibaldi RA et al (1985) Evidence for the non-infectious etiology of early postoperative fever. Infect Control 6(7):273–277
Wortel CH et al (1993) Interleukin-6 mediates host defense responses induced by abdominal surgery. Surgery 114(3):564–570
Badillo AT, Sarani B, Evans SR (2002) Optimizing the use of blood cultures in the febrile postoperative patient. J Am Coll Surg 194(4):477–487
Japanese Gastric Cancer Association (2011) Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer 2:113–123
Biondi A, Hyung WJ, Hyung WJ (2011) Seventh edition of TNM classification for gastric cancer. J Clin Oncol 29:4338–4339
Wente MN, Veit JA, Bassi C, Dervenis C, Fingerhut A, Gouma DJ et al (2007) Postpancreatectomy hemorrhage (PPH): an International Study Group of Pancreatic Surgery (ISGPS) definition. Surgery 142:20–25
Jung MR, Park YK, Seon JW, Kim KY, Cheong O, Ryu SY (2012) Definition and classification of complications of gastrectomy for gastric cancer based on the accordion severity grading system. World J Surg 36:2400–2411. https://doi.org/10.1007/s00268-012-1693-y
Bruce J, Krukowski ZH, Al-Khairy G, Russell EM, Park KG (2001) Systematic review of the definition and measurement of anastomotic leak after gastrointestinal surgery. Br J Surg 88:1157–1168
Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J et al (2005) Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 138:8–13
Orsenigo E, Bissolati M, Socci C, Chiari D, Muffatti F, Nifosi J et al (2014) Duodenal stump fistula after gastric surgery for malignancies: a retrospective analysis of risk factors in a single centre experience. Gastric Cancer 17:733–744
Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG (1992) CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 13:606–608
Assumpcao L, Cameron JL, Wolfgang CL, Edil B, Choti MA, Herman JM et al (2008) Incidence and management of chyle leaks following pancreatic resection: a high volume single-center institutional experience. J Gastrointest Surg 12:1915–1923
Holte K, Kehlet H (2000) Postoperative ileus: a preventable event. Br J Surg 87:1480–1493
Dindo D, Demartines N, Clavien PA et al (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213
Kubota T et al (2014) Prognostic significance of complications after curative surgery for gastric cancer. Ann Surg Oncol 21(3):891–898
Camp RL, Dolled-Filhart M, Rimm DL (2004) X-tile: a new bioinformatics tool for biomarker assessment and outcome-based cut- point optimization. Clin Cancer Res 21:7252–7259
Guan X, Chen W, Jiang Z et al (2016) Exploration of the optimal minimum lymph node count after colon cancer resection for patients aged 80 years and older. Sci Rep 1:1. https://doi.org/10.1038/srep38901
Sietses C, Beelen RH, Meijer S et al (1999) Immunological consequences of laparoscopic surgery, speculations on the cause and clinical implications. Langenbecks Arch Surg 384(3):250–258
Bar-Yosef S, Melamed R, Page GG et al (2001) Attenuation of the tumor-promoting effect of surgery by spinal blockade in rats. Anesthesiology 94(6):1066–1073
Beilin B, Shavit Y, Hart J et al (1996) Effects of anesthesia based on large versus small doses of fentanyl on natural killer cell cytotoxicity in the perioperative period. Anesth Analg 82(3):492–497
Beilin B, Shavit Y, Razumovsky J et al (1998) Effects of mild perioperative hypothermia on cellular immune responses. Anesthesiology 89(5):1133–1140
Salman H, Bergman M, Bessler H et al (2000) Hypothermia affects the phagocytic activity of rat peritoneal macrophages. Acta Physiol Scand 168(3):431–436
Page GG, Blakely WP, Ben-Eliyahu S (2001) Evidence that postoperative pain is a mediator of the tumor-promoting effects of surgery in rats. Pain 90(1–2):191–199
Xu YX, Ayala A, Chaudry IH (1998) Prolonged immunodepression after trauma and hemorrhagic shock. J Trauma 44(2):335–341
Klein HG (1999) Immunomodulatory aspects of transfusion: a once and future risk? Anesthesiology 91(3):861–865
Cohen S, Herbert TB (1996) Health psychology: psychological factors and physical disease from the perspective of human psychoneuroimmunology. Annu Rev Psychol 47:113–142
Moynihan JA, Ader R (1996) Psychoneuroimmunology: animal models of disease. Psychosom Med 58(6):546–558
Ishihara Y, Matsunaga K, Iijima H et al (1999) Time-dependent effects of stressor application on metastasis of tumor cells in the lung and its regulation by an immunomodulator in mice. Psychoneuroendocrinology 24(7):713–726
Faist E, Schinkel C, Zimmer S (1996) Update on the mechanisms of immune suppression of injury and immune modulation. World J Surg 20(4):454–459. https://doi.org/10.1007/s002689900071
Shakhar G, Ben-Eliyahu S (2003) Potential prophylactic measures against postoperative immunosuppression: could they reduce recurrence rates in oncological patients? Ann Surg Oncol 10(8):972–992. https://doi.org/10.1245/ASO.2003.02.007
Goldfarb Y et al (2011) Improving postoperative immune status and resistance to cancer metastasis: a combined perioperative approach of immunostimulation and prevention of excessive surgical stress responses. Ann Surg 253(4):798–810
Wojtowicz-Praga S (1997) Reversal of tumor-induced immunosuppression: a new approach to cancer therapy. J Immunother 20(3):165–177
Chattopadhyay S, Bhattacharya S, Saha B et al (2009) Tumor-shed PGE(2) impairs IL2Rgammac-signaling to inhibit CD4 T cell survival: regulation by theaflavins. PLoS ONE 4(10):e7382
Saito T, Kurokawa Y, Miyazaki Y et al (2015) Which is a more reliable indicator of survival after gastric cancer surgery: postoperative complication occurrence or C-reactive protein elevation? J Surg Oncol 112:894–899
Acknowledgements
We are thankful to Fujian Medical University Union Hospital for their management of our gastric cancer patient database.
Funding
The study was sponsored by the Scientific and technological innovation joint capital projects of Fujian Province (2016Y9031); Construction Project of Fujian Province Minimally Invasive Medical Center (No. [2017]171); the second batch of special support funds for Fujian Province Innovation and Entrepreneurship Talents (2016B013); Youth Scientific Research Subject of Fujian Provincial Health and Family Planning Commission (No. 2015-1-37); QIHANG funds of Fujian Medical University (No. 2016QH025); and Chinese physicians association young physician respiratory research fund of Fujian Province Medical Innovation Project (2015-CXB-16).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
268_2019_4965_MOESM1_ESM.tif
Supplementary Figure 1 5-year overall survival and disease-specific survival for stage III patients with no complication. (TIFF 585 kb)
268_2019_4965_MOESM3_ESM.tif
Supplementary Figure 3 5-year disease-free survival: LTG VS HTG in patients with infectious complications. (TIFF 779 kb)
Rights and permissions
About this article
Cite this article
Zheng, HL., Lu, J., Li, P. et al. Effect of High Postoperative Body Temperature on Long-Term Prognosis in Patients with Gastric Cancer After Radical Resection. World J Surg 43, 1756–1765 (2019). https://doi.org/10.1007/s00268-019-04965-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-019-04965-5